This invention relates in general to intravascular catheters, such as can be used during minimally invasive surgical procedures. In particular, this invention relates to an intravascular catheter having an expandable incising portion.
Atherosclerosis is a chronic condition in which atheromatous plaque accumulates on the inner walls of a blood vessel. As a result, the blood vessel walls can become inflamed and, over time, may harden to form atherosclerotic lesions that cause a narrowing of the vessel lumen. In severe cases, the atherosclerotic lesions can rupture and induce the formation of thrombus (i.e., blood clots), which can prevent blood flow through the narrowed vessel lumen.
There are known procedures and devices for treating or otherwise reducing the risks associated with atherosclerosis. For example, an angioplasty is a procedure in which a balloon catheter is inserted into a narrowed region of the vessel lumen via a delivery catheter. The balloon catheter includes a flexible tube having an inflatable balloon at an end thereof. Once positioned in the narrowed region, the balloon is inflated in order to dilate the narrowed vessel lumen. The pressure in the balloon is generally sufficient to compress the accumulated plaque. However, in some cases it would be desirable to fragment the atherosclerotic lesions. Thus, it would be desirable to provide an intravascular catheter having an expandable portion that can be selectively controlled by a user and adapted to create incisions in atherosclerotic material to facilitate fragmentation of the material during an angioplasty procedure.
There are known devices that perform atherectomy by abrading atherosclerotic tissue though high speed rotational movement. Such devices include the Diamondback 360® by Cardiovascular Systems, Inc. (http://www.csi360.com/products/coronary-diamondback-360-coronary-orbital-atherectomy-system-crowns/) and the Rotablator™ by Boston Scientific™ (http://www.bostonscientific.com/en-US/products/plaque-modification/rotablator-rotational-atherectomy-system.html). These devices are complex, requiring high speed motors and control systems to operate the motors. In some cases, it would be desirable to remove atherosclerotic material by micro-abrasion. Thus, it would be desirable to provide an intravascular catheter having an expandable portion and also having an abrasive surface for abrading atherosclerotic material by forward and backwards lateral movement.
This invention relates to an intravascular catheter device for use during a surgical procedure. The catheter device includes a catheter tube having an expandable portion with a plurality of struts each defining an outer surface. The expandable portion is operable between a closed position, wherein the expandable portion has a first diameter, and an opened position, wherein the expandable portion has a second diameter that is larger than the first diameter. An incising element is provided on the outer surface of at least one of the struts. The incising element has a sharpened edge that extends outwardly in a radial direction from the outer surface of the strut for creating an incision in atherosclerotic material located within a blood vessel when the expandable portion is in the opened position.
This invention also relates to an intravascular catheter having an expandable portion and also having abrasive surfaces. The abrasive surfaces may be located on the outer surface of the struts and may be configured to score, roughen, or remove through micro-abrasion of atherosclerotic material when the expandable portion is in the opened position and moved longitudinally within a blood vessel. The abrasive surface may be located on any portion of one or more struts and may be used with or without the incising elements.
Various aspects of this invention will become apparent to those skilled in the art from the following detailed description of the preferred embodiments, when read in light of the accompanying drawings.
Referring now to the drawings, there is illustrated in
Referring now to
As shown in
The illustrated handle assembly 20 also includes a control member 25 that is supported on the handle body 21 for sliding movement within the slot 24. For example, the control member 25 is movable between a forward position (shown in
The illustrated handle assembly 20 also includes a locking mechanism 27 that is configured to temporarily secure the control member 25 in a desired position, although such is not required. As shown in
Referring now to
As shown in
As shown in
The illustrated expandable portion 32 has a pair of struts 34A and 34B. The illustrated struts 34A and 34B are separated by a pair of longitudinally extending slits 35A and 35B that extend through side walls of the expandable portion 32. As shown in
As shown in
The distal end of the expandable portion 32 may optionally include a tip member 38. The illustrated tip member 38 has a generally conical shape that facilitates insertion of the catheter tube 30 within a blood vessel 50 (see
As shown in
As shown in
As shown in
Referring back to
The illustrated protective sheath 42 includes a flange 44 that facilitates sliding movement of the protective sheath 42 relative to the catheter tube 30. The illustrated flange 44 is an annular member that is located at an end of the protective sheath 42 nearest the handle assembly 20. The flange 44 can be integrally formed with the protective sheath 42 or may otherwise be secured thereto in any manner, such as with an adhesive or the like. It should be appreciated that the flange 44 can have any shape or may alternatively be configured in any manner to accomplish the functions described herein and below.
The operation of the catheter device 10 will now be described with reference to
When the catheter device 10 is in the first operating mode, the distal end of the catheter tube 30 can be percutaneously inserted into a blood vessel 50, as shown in
Once the expandable portion 32 is positioned in the narrowed region of the blood vessel 50, the incising elements 36 can be exposed by sliding the protective sheath 42 back from the distal end of the catheter tube 30, as indicated by the direction arrows in
Referring now to
During operation of the catheter device 10, the second diameter D2 can be increased or decreased by selective movement of the control member 25 between the forward and rearward positions. For example, a larger second diameter D2 can be achieved by moving the control member 25 further towards the rearward position. Conversely, a smaller second diameter D2 can be achieved by moving the control member 25 further towards the forward position. The visual indicator 24A can be used to identify the instantaneous second diameter D2 of the expandable portion 32. Alternatively (or in addition), the struts 34A and 34B may be biased in the opened position so as to automatically expand outwardly to the second diameter D2 when the protective sheath 42 is slid back from the expandable portion 32. As such, sliding movement of the protective sheath 42 relative to the struts 34A and 34B can be used to selectively control the second diameter D2. In this configuration, the inner sleeve 40 and the movable components of the handle assembly 20 may not be necessary.
When the catheter device 10 is in the second operating mode, the expandable portion 32 can be pulled along the guide wire 52 through the narrowed region of the blood vessel 50. This can be accomplished by pulling on the handle assembly 20. In doing so, the incising elements 36 engage the atherosclerotic material 54 and create longitudinal incisions 56 therein. As shown in
Alternatively, the catheter device 10 can be used to create additional incisions 56 in the atherosclerotic material 54. For example, after the catheter device 10 has been returned to the first operating mode, the expandable portion 32 can be relocated within the narrowed region of the blood vessel 50. The catheter tube 30 can then be rotated within the blood vessel 50 by rotating the handle assembly 20 so as to align the incising elements 36 with other portions of the atherosclerotic material 54. The previous steps can then be repeated any number of times to make multiple passes through the narrowed region of the blood vessel 50 and create additional incisions in the atherosclerotic material 54.
Thus, it should be appreciated that the illustrated catheter device 10 is advantageous in many respects. In one example, the second diameter D2 of the expandable portion 32 can be selectively controlled by operation of the handle assembly 20 or by sliding movement of the protective sheath 42. This enables the catheter device 10 to be adapted for use in blood vessels 50 of different sizes or varying diameters. In another example, the illustrated catheter device 10 can apply varying magnitudes of radial forces to the atherosclerotic material 54 by controlling the amount of force being applied to the control member 25 on the handle assembly 20. This enables the catheter device 10 to generate sufficient radial force to create incisions 56 in atherosclerotic material 54 while reducing the potential for tearing the walls of the blood vessel 50. In yet another example, the catheter device 10 can be used to make any number of passes during a single procedure to make multiple incisions 56 in atherosclerotic material 54 of varying lengths and shapes.
Referring now to
For example, the catheter tube 130 may extend from a handle assembly (not shown) as described above in the first embodiment. The expandable portion 132 is provided on a distal end of the catheter tube 130 and may include a tip member 138. The catheter tube 130 may also include an inner sleeve 140 and a protective sheath (not shown), which is also described above in the first embodiment.
In the illustrated embodiment, however, the expandable portion 132 includes four struts 134A, 134B, 134C, and 134D that are respectively separated by four longitudinally extending slits 135A, 135B, 135C, and 135D. The illustrated struts 134A, 134B, 134C, and 134D each include an incising element 136, although such is not required. It should be appreciated that the expandable portion 132 may have any number or configuration of struts and incising elements as desired.
As shown in
The expandable portion 132 can be operated between a closed position (shown in
Referring now to
For example, the catheter tube 230 may extend from a handle assembly (not shown) as described above in the first embodiment. The expandable portion 232 is provided on a distal end of the catheter tube 230 and includes a pair of struts 234A and 234B that are separated by a pair of longitudinally extending slits 235A and 235B. The catheter tube 230 may also include a tip member 238, an inner sleeve 240, and a protective sheath (not shown), which is described above in the first embodiment. The guide wire 252 may extend through the entire device.
In the illustrated embodiment, however, the expandable portion 232 includes a first pair of weakened regions 237A, 237B and a second pair of weakened regions 239A, 239B that are respectively located at opposite ends of the struts 234A and 234B. The illustrated weakened regions 237A, 237B and 239A, 239B are formed by enlarged apertures that extend through side walls of the expandable portion 232 that function as hinges. The weakened regions 237A, 237B and 239A, 239B may help reduce the amount of bending stress in the side walls of the expandable portion 232 when the struts 234A and 234B are moved to an opened position. The struts 234A and 234B may include any number or configuration of weakened regions. Further, it should be appreciated that any of the other embodiments in this disclosure may also include weakened regions 237A, 237B and 239A, 239B.
The illustrated struts 234A and 234B remain generally flat along respective lengths thereof in both a closed position (shown in
As shown in
The expandable portion 232 can be operated between the closed position and the opened position by selective movement of the inner sleeve 240 relative to the catheter tube 230, as described above in the first embodiment. Alternatively (or in addition), the struts 234A and 234B can be biased in the opened position. In such an embodiment, the protective sheath (not shown) can be used to effect movement of the expandable portion 232 between the closed position and the opened position.
Referring now to
For example, the catheter tube 330 may extend from a handle assembly (not shown) as described above in the first embodiment. The expandable portion 332 is provided on a distal end of the catheter tube 330 and may include a tip member 338. The catheter tube 330 may also include an inner sleeve 340 that is attached to the tip member 338 and a protective sheath (not shown), which is also described above in the first embodiment. The guide wire 352 may extend through the entire device.
In the illustrated embodiment, however, the expandable portion 332 includes a pair of struts 334A and 334B that are supported thereon in a cantilevered manner (i.e., not attached to one another or to the tip member 338 at their distal ends), the purpose of which will be explained below. The struts 334A and 334B are separated by a pair of longitudinally extending slits 335A and 335B that extend from the end of the expandable portion 332. A pair of incising elements 336 is respectively provided along outer surfaces of the struts 334A and 334B. It should be appreciated, however, that the expandable portion 332 may have any number or configuration of struts and incising elements as desired.
As shown in
The struts 334A and 334B remain generally flat along their respective lengths in both a closed position (shown in
As shown in
Regardless, the abrasive surface 142 may be of any grit size, though exemplary embodiments may be a 30-70 micron grit, inclusive. The abrasive surface 142 may extend over the entire length or over any portion of the struts 134A-C. For example, but not to serve as a limitation, the abrasive surface 142 may be limited to the area around the incising element 136, the proximal half of the struts 134A-C, or the distal half of the struts 134A-C. Likewise, the abrasive surface 142 may be located on any number of the struts 134A-C.
The abrasive surface 142 may be configured to contact and score, roughen, move, micro-abrade and/or otherwise abrade atherosclerotic material 54 located in the blood vessel 50 when the expandable portion 132 is placed in the opened position and moved axially forwards and/or backwards through the blood vessel 50. Any type of abrasion where a substance is broken into smaller particulate is contemplated. In exemplary embodiments of the present invention, the atherosclerotic material 54 is abraded into very fine particulate, preferably on the micron order of magnitude though any type of abrasion into any size particulate is contemplated. Although reference is made to abrading atherosclerotic material 54, it is contemplated that the present invention may additionally be configured and/or used to abrade other structures or blockages located within or that form a part of the vascular system. More specifically, the incising element 136 may enter the atherosclerotic material 54, thus fragmenting it, while the struts 134A-C and the abrasive surface 142 thereon may ride across the surface of the atherosclerotic material 54, thus abrading it. In other exemplary embodiments of the present invention where the incising elements 136 are not used, the abrasive surface 142 may simply abrade the surface of the atherosclerotic material 54 by lateral movement of the expandable portion 132.
The abrasive surface 142 may abrade the atherosclerotic material 54 into sufficiently small pieces that it can be reabsorbed by the body, such as but not limited to through the blood vessel 50 wall, or travel safely through the vascular system. In other exemplary embodiments, the abrasive surface 142 may abrade the atherosclerotic material 54 to facilitate and enhance the effectiveness of further treatment, such as but not limited, angioplasty. For example, but not to serve as a limitation, the abrasive surface 142 may break the surface tension on the atherosclerotic material 54, thus making subsequent angioplasty more effective.
Similarly,
The embodiments in
The principle and mode of operation of this invention have been explained and illustrated in its preferred embodiments. However, it must be understood that this invention may be practiced otherwise than as specifically explained and illustrated without departing from its spirit or scope.
This application is a continuation of U.S. application Ser. No. 15/441,398 filed Feb. 24, 2017, the disclosures of which are hereby incorporated by reference as if fully restated herein.
Number | Name | Date | Kind |
---|---|---|---|
2655154 | Richter | Nov 1951 | A |
3557794 | Van Patten | Jan 1971 | A |
3704711 | Park | Dec 1972 | A |
4273128 | Banning | Jun 1981 | A |
4292974 | Fogarty et al. | Oct 1981 | A |
4654027 | Dragan et al. | Mar 1987 | A |
5030201 | Palestrant | Jul 1991 | A |
5074817 | Song | Dec 1991 | A |
5074871 | Groshong | Dec 1991 | A |
5100425 | Fischell et al. | Mar 1992 | A |
5154724 | Andrews | Oct 1992 | A |
5156610 | Reger | Oct 1992 | A |
5178625 | Groshong | Jan 1993 | A |
5211651 | Reger et al. | May 1993 | A |
5224945 | Pannek, Jr. | Jul 1993 | A |
5244619 | Burnham | Sep 1993 | A |
5246421 | Saab | Sep 1993 | A |
5250060 | Carbo et al. | Oct 1993 | A |
5282484 | Reger | Feb 1994 | A |
5312427 | Shturman | May 1994 | A |
5318576 | Plassche, Jr. et al. | Jun 1994 | A |
5376100 | Lefebvre | Dec 1994 | A |
5514093 | Ellis et al. | May 1996 | A |
5591194 | Berthiaume | Jan 1997 | A |
5658309 | Berthiaume et al. | Aug 1997 | A |
5665098 | Kelly et al. | Sep 1997 | A |
5676654 | Ellis et al. | Oct 1997 | A |
5697944 | Lary | Dec 1997 | A |
5697948 | Marin et al. | Dec 1997 | A |
5728067 | Enger | Mar 1998 | A |
5728123 | Lemelson et al. | Mar 1998 | A |
5733296 | Rogers et al. | Mar 1998 | A |
5766192 | Zacca | Jun 1998 | A |
5792158 | Lary | Aug 1998 | A |
5800450 | Lary et al. | Sep 1998 | A |
5836868 | Ressemann et al. | Nov 1998 | A |
5876448 | Thompson et al. | Mar 1999 | A |
5961536 | Mickley et al. | Oct 1999 | A |
5968064 | Selmon et al. | Oct 1999 | A |
6071287 | Verbeek | Jun 2000 | A |
6120515 | Rogers et al. | Sep 2000 | A |
6129708 | Enger | Oct 2000 | A |
6165187 | Reger | Dec 2000 | A |
6217549 | Selmon et al. | Apr 2001 | B1 |
6258108 | Lary | Jul 2001 | B1 |
6270489 | Wise et al. | Aug 2001 | B1 |
6283947 | Mirzaee | Sep 2001 | B1 |
6527740 | Jackson et al. | Mar 2003 | B1 |
6599267 | Ray et al. | Jul 2003 | B1 |
6692466 | Chow et al. | Feb 2004 | B1 |
6695863 | Ramzipoor et al. | Feb 2004 | B1 |
6719773 | Boucher et al. | Apr 2004 | B1 |
6884257 | Cox | Apr 2005 | B1 |
7108704 | Trerotola | Sep 2006 | B2 |
7131981 | Appling et al. | Nov 2006 | B2 |
7172614 | Boyle et al. | Feb 2007 | B2 |
7279002 | Shaw et al. | Oct 2007 | B2 |
7303572 | Melsheimer et al. | Dec 2007 | B2 |
7329267 | Weber | Feb 2008 | B2 |
7517352 | Evans et al. | Apr 2009 | B2 |
7686824 | Konstantino et al. | Mar 2010 | B2 |
7691086 | Tkebuchava | Apr 2010 | B2 |
7708753 | Hardert | May 2010 | B2 |
7850685 | Kunis et al. | Dec 2010 | B2 |
7850710 | Huss | Dec 2010 | B2 |
7887557 | Kelley et al. | Feb 2011 | B2 |
7914549 | Morsi | Mar 2011 | B2 |
7955350 | Konstantino et al. | Jun 2011 | B2 |
8308754 | Belson | Nov 2012 | B2 |
8323307 | Hardert | Dec 2012 | B2 |
8328829 | Olson | Dec 2012 | B2 |
8348987 | Eaton | Jan 2013 | B2 |
8366661 | Weber et al. | Feb 2013 | B2 |
8398662 | Granada et al. | Mar 2013 | B2 |
8430904 | Belson | Apr 2013 | B2 |
8454636 | Konstantino et al. | Jun 2013 | B2 |
8500789 | Wuebbeling et al. | Aug 2013 | B2 |
8685049 | Schur et al. | Apr 2014 | B2 |
8685050 | Schur et al. | Apr 2014 | B2 |
8702736 | Schur et al. | Apr 2014 | B2 |
8740849 | Fischell et al. | Jun 2014 | B1 |
8870816 | Chambers et al. | Oct 2014 | B2 |
8968354 | Wang et al. | Mar 2015 | B2 |
8974490 | Jonsson | Mar 2015 | B2 |
9039727 | Kusleika | May 2015 | B2 |
9079000 | Hanson et al. | Jul 2015 | B2 |
9192747 | Hardert | Nov 2015 | B2 |
9282991 | Schur et al. | Mar 2016 | B2 |
9314329 | Dickinson et al. | Apr 2016 | B2 |
9364255 | Weber | Jun 2016 | B2 |
9364284 | Groff et al. | Jun 2016 | B2 |
9510901 | Steinke et al. | Dec 2016 | B2 |
9532798 | Schur et al. | Jan 2017 | B2 |
9545263 | Lenihan et al. | Jan 2017 | B2 |
9592386 | Mathur et al. | Mar 2017 | B2 |
9604036 | Burton et al. | Mar 2017 | B2 |
9615848 | Pigott | Apr 2017 | B2 |
10463387 | Pigott | Nov 2019 | B2 |
10485572 | Pigott | Nov 2019 | B2 |
10610255 | Pigott | Apr 2020 | B2 |
10842971 | Iwano et al. | Nov 2020 | B2 |
10874837 | Iwano et al. | Dec 2020 | B2 |
20010007059 | Mirzaee | Jul 2001 | A1 |
20020010489 | Grayzel et al. | Jan 2002 | A1 |
20020029052 | Evans et al. | Mar 2002 | A1 |
20020143350 | Heitzmann et al. | Oct 2002 | A1 |
20020143362 | Macovial et al. | Oct 2002 | A1 |
20020161394 | Macoviak et al. | Oct 2002 | A1 |
20030069547 | Gonon | Apr 2003 | A1 |
20030125756 | Shturman et al. | Jul 2003 | A1 |
20030144677 | Lary | Jul 2003 | A1 |
20030208215 | Uflacker | Nov 2003 | A1 |
20040034384 | Fukaya | Feb 2004 | A1 |
20040098014 | Flugelman | May 2004 | A1 |
20040122457 | Weber | Jun 2004 | A1 |
20040204738 | Weber et al. | Oct 2004 | A1 |
20040267345 | Lorenzo et al. | Dec 2004 | A1 |
20050055077 | Marco et al. | Mar 2005 | A1 |
20050149102 | Radisch et al. | Jul 2005 | A1 |
20050149159 | Andreas et al. | Jul 2005 | A1 |
20050151304 | Boelens et al. | Jul 2005 | A1 |
20050240176 | Oral et al. | Oct 2005 | A1 |
20060020285 | Niermann | Jan 2006 | A1 |
20060089637 | Werneth et al. | Apr 2006 | A1 |
20060111736 | Kelley | May 2006 | A1 |
20060116701 | Crow | Jun 2006 | A1 |
20060184191 | O'Brien | Aug 2006 | A1 |
20060253148 | Leone et al. | Nov 2006 | A1 |
20070005093 | Cox | Jan 2007 | A1 |
20070060863 | Goeken et al. | Mar 2007 | A1 |
20070083194 | Kunis et al. | Apr 2007 | A1 |
20070106215 | Olsen et al. | May 2007 | A1 |
20070156225 | George et al. | Jul 2007 | A1 |
20070181157 | Dadourian | Aug 2007 | A1 |
20080140051 | Bei et al. | Jun 2008 | A1 |
20080294116 | Wolter et al. | Nov 2008 | A1 |
20080300594 | Goto | Dec 2008 | A1 |
20080300610 | Chambers | Dec 2008 | A1 |
20090099583 | Butterfield et al. | Apr 2009 | A1 |
20090105686 | Snow et al. | Apr 2009 | A1 |
20090192508 | Laufer et al. | Jul 2009 | A1 |
20090204068 | Nguyen et al. | Aug 2009 | A1 |
20090254172 | Grewe | Oct 2009 | A1 |
20090306690 | Rivers | Dec 2009 | A1 |
20090312807 | Boudreault et al. | Dec 2009 | A1 |
20100010521 | Kurrus | Jan 2010 | A1 |
20100023035 | Kontos | Jan 2010 | A1 |
20100076482 | Shu et al. | Mar 2010 | A1 |
20100121270 | Gunday et al. | May 2010 | A1 |
20100168737 | Grunewald | Jul 2010 | A1 |
20100168778 | Braido | Jul 2010 | A1 |
20100330147 | Hossainy et al. | Dec 2010 | A1 |
20110060182 | Kassab et al. | Mar 2011 | A1 |
20110152683 | Gerrans et al. | Jun 2011 | A1 |
20110160645 | Sutermeister et al. | Jun 2011 | A1 |
20110184447 | Leibowitz et al. | Jul 2011 | A1 |
20110288479 | Burton | Nov 2011 | A1 |
20120053485 | Bloom | Mar 2012 | A1 |
20120143054 | Eaton et al. | Jun 2012 | A1 |
20120150142 | Weber et al. | Jun 2012 | A1 |
20120157988 | Stone et al. | Jun 2012 | A1 |
20120172901 | Manderfeld et al. | Jul 2012 | A1 |
20130066346 | Pigott | Mar 2013 | A1 |
20130116715 | Weber | May 2013 | A1 |
20130131594 | Bonnette et al. | May 2013 | A1 |
20130150874 | Kassab | Jun 2013 | A1 |
20130237950 | Gianotti et al. | Sep 2013 | A1 |
20130253467 | Gianotti et al. | Sep 2013 | A1 |
20140121672 | Folk | May 2014 | A1 |
20140257367 | Jonsson | Sep 2014 | A1 |
20140257368 | Jonsson | Sep 2014 | A1 |
20140277002 | Grace | Sep 2014 | A1 |
20140350523 | Dehdashtian et al. | Nov 2014 | A1 |
20140364896 | Consigny | Dec 2014 | A1 |
20140371783 | Shu et al. | Dec 2014 | A1 |
20150133978 | Paul, Jr. | May 2015 | A1 |
20150182324 | Naor et al. | Jul 2015 | A1 |
20160143721 | Rosenbluth et al. | May 2016 | A1 |
20170056048 | Erpen | Mar 2017 | A1 |
20170238960 | Hatta et al. | Aug 2017 | A1 |
20180177985 | Nakagawa et al. | Jun 2018 | A1 |
20200289102 | Wilson et al. | Sep 2020 | A1 |
20200297376 | Marks et al. | Sep 2020 | A1 |
20210023347 | Iwano et al. | Jan 2021 | A1 |
20210220008 | Pigott | Jul 2021 | A1 |
Number | Date | Country |
---|---|---|
0727194 | Aug 1996 | EP |
02078511 | Oct 2002 | NO |
8102109 | Aug 1981 | WO |
9502370 | Jan 1995 | WO |
1996039997 | Dec 1996 | WO |
9918862 | Apr 1999 | WO |
02078511 | Oct 2002 | WO |
2007095125 | Aug 2007 | WO |
2013159066 | Oct 2013 | WO |
2013169596 | Nov 2013 | WO |
2014106226 | Jul 2014 | WO |
2014142801 | Sep 2014 | WO |
2015190578 | Dec 2015 | WO |
2015195606 | Dec 2015 | WO |
2016210167 | Dec 2016 | WO |
Entry |
---|
Cardiovascular Systems Inc., Diamondback 360 Coronary Orbital Atherectomy System, http://www.csi360.com/products/coronary-diamondback-360-coronary-orbital-atherectomy-system-crowns/, 2016. |
Boston Scientific Corporation, FilterWire EZ, Embolic Protection System for Carotid Arteries, Sep. 2015, http://www.bostonscientific.com/en-US/products/embolic-protection/filterwire-ez-embolic-protection-system.html. |
International Search Report, Application No. PCT/US2012/055079, dated Jan. 31, 2013. |
Boston Scientific, Rotablator Rotational Atherectomy System, http://www.bostonscientific.com/en-US/products/plaque-modification/rotablator-rotational-atherectomy-system.html, 2017. |
Covidien, SpiderFX Embolic Protection Device, 2015, https://www.ev3.net/peripheral/US/embolic-protection/spiderfxtrade-embolic-protection-device.htm. |
Boston Scientific, Sterling 0.018″ Balloon Catheter, Jun. 2015. |
Ham, S. et al., Safety of Carbon Dioxide Digital Subtraction Angiography, Archives of Surgery, Dec. 2011. |
Alexander, J., CO2 Angiography in Lower Extremity Arterial Disease, Endovascular Today, Sep. 2011, pp. 27-34. |
Number | Date | Country | |
---|---|---|---|
20220240974 A1 | Aug 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15441398 | Feb 2017 | US |
Child | 17728214 | US |